BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32035746)

  • 1. Innate inflammation drives NK cell activation to impair Treg activity.
    Dean JW; Peters LD; Fuhrman CA; Seay HR; Posgai AL; Stimpson SE; Brusko MA; Perry DJ; Yeh WI; Newby BN; Haller MJ; Muir AB; Atkinson MA; Mathews CE; Brusko TM
    J Autoimmun; 2020 Mar; 108():102417. PubMed ID: 32035746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
    Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
    Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
    Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
    Front Immunol; 2019; 10():19. PubMed ID: 30723474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice.
    Koprivica I; Vujičić M; Gajić D; Saksida T; Stojanović I
    Front Immunol; 2018; 9():3130. PubMed ID: 30687329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
    Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
    Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired NK cells' activity and increased numbers of CD4 + CD25+ regulatory T cells in multidrug-resistant Mycobacterium tuberculosis patients.
    Fan R; Xiang Y; Yang L; Liu Y; Chen P; Wang L; Feng W; Yin K; Fu M; Xu Y; Wu J
    Tuberculosis (Edinb); 2016 May; 98():13-20. PubMed ID: 27156613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 9. Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
    Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
    Cancer Immunol Res; 2018 Jul; 6(7):766-775. PubMed ID: 29784636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells.
    Lindenberg M; Solmaz G; Puttur F; Sparwasser T
    Virol J; 2014 Aug; 11():145. PubMed ID: 25108672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
    Gianchecchi E; Delfino DV; Fierabracci A
    Front Immunol; 2021; 12():616853. PubMed ID: 33679757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
    Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
    Front Immunol; 2018; 9():907. PubMed ID: 29774027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of CD226-TIGIT
    Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
    Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
    Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.
    Jin X; Zhang C; Gong L; Li H; Wang Y; Li Q; Li H
    J Diabetes; 2019 Jun; 11(6):440-448. PubMed ID: 30318734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of IL-2, IL-12 and IL15 on the function of natural killer cells in children suffering from type 1 diabetes mellitus.
    Chrul S; Polakowska E; Mycko M; Fendler W; Zwiech R; Szadkowska A
    Pediatr Endocrinol Diabetes Metab; 2013; 19(3):91-5. PubMed ID: 25577895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-pig NK cell and CD8
    Madelon N; Puga Yung GL; Seebach JD
    Xenotransplantation; 2016 Nov; 23(6):479-489. PubMed ID: 27862343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
    Todd JA; Evangelou M; Cutler AJ; Pekalski ML; Walker NM; Stevens HE; Porter L; Smyth DJ; Rainbow DB; Ferreira RC; Esposito L; Hunter KM; Loudon K; Irons K; Yang JH; Bell CJ; Schuilenburg H; Heywood J; Challis B; Neupane S; Clarke P; Coleman G; Dawson S; Goymer D; Anselmiova K; Kennet J; Brown J; Caddy SL; Lu J; Greatorex J; Goodfellow I; Wallace C; Tree TI; Evans M; Mander AP; Bond S; Wicker LS; Waldron-Lynch F
    PLoS Med; 2016 Oct; 13(10):e1002139. PubMed ID: 27727279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Characteristics of TIGIT-Expressing CD3
    Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
    Front Immunol; 2021; 12():602492. PubMed ID: 33717085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.